Quest Patent Research (QPRC) Cash & Equivalents (2009 - 2026)
Quest Patent Research (QPRC) posted Cash & Equivalents of $619861.0 for Q1 2026, up 221.83% sequentially from $192606.0 in Q4 2025, and up 1196.18% YoY from $47822.0 in Q1 2025.
Quest Patent Research (QPRC) Cash & Equivalents (2009 - 2026) Analysis & Trends
Quest Patent Research has reported Cash & Equivalents for 18 years, with the latest figure at $619861.0 in Q1 2026.
- Quarterly Cash & Equivalents rose 1196.18% year-over-year to $619861.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $619861.0 (up 1196.18% YoY) and the FY2025 annual result came in at $192606.0, down 60.04% from the prior year.
- Cash & Equivalents grew to $619861.0 in Q1 2026 per QPRC's latest filing, from $192606.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $770696.0 in Q1 2024 and troughed at $47822.0 in Q1 2025.
- A 5-year average of $288006.9 and a median of $192606.0 in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2025 and 2026: Cash & Equivalents slumped 93.79% in 2025, then jumped 1196.18% in 2026.
- Over 5 years, Cash & Equivalents stood at $90601.0 in 2022, then soared by 521.94% to $563484.0 in 2023, then dropped by 14.46% to $482023.0 in 2024, then tumbled by 60.04% to $192606.0 in 2025, then jumped by 221.83% to $619861.0 in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $619861.0, $192606.0, and $175141.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.84 Bn | 81.56 Bn | 1.48 Bn | 289.02 Mn |
| 2 | Relx | 65.92 Bn | 65.74 Bn | - | 174.25 Mn |
| 3 | Copart | 31.68 Bn | 28.33 Bn | 732.88 Mn | 3.35 Bn |
| 4 | Global Payments | 25.34 Bn | 19.93 Bn | 2.03 Bn | 5.41 Bn |
| 5 | Rb Global | 16.15 Bn | 15.62 Bn | 935.50 Mn | 524.90 Mn |
| 6 | Aramark | 15.72 Bn | 15.22 Bn | 430.34 Mn | 499.43 Mn |
| 7 | UL Solutions | 15.16 Bn | 14.72 Bn | 417.00 Mn | 434.00 Mn |
| 8 | Rentokil Initial | 11.92 Bn | 9.40 Bn | - | 2.47 Bn |
| 9 | Dolby Laboratories | 6.14 Bn | 5.47 Bn | 264.68 Mn | 669.39 Mn |
| 10 | Quest Patent Research | 1.33 Mn | 852,615.25 | -348,206.00 | 480,606.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 619,861.00 |
| Dec 31, 2025 | 192,606.00 |
| Sep 30, 2025 | 175,141.00 |
| Jun 30, 2025 | 254,659.00 |
| Mar 31, 2025 | 47,822.00 |
| Dec 31, 2024 | 482,023.00 |
| Sep 30, 2024 | 136,782.00 |
| Jun 30, 2024 | 136,767.00 |
| Mar 31, 2024 | 770,696.00 |
| Dec 31, 2023 | 563,484.00 |
| Sep 30, 2023 | 611,466.00 |
| Jun 30, 2023 | 128,497.00 |
| Mar 31, 2023 | 126,906.00 |
| Dec 31, 2022 | 90,601.00 |
| Sep 30, 2022 | 75,968.00 |
| Jun 30, 2022 | 228,164.00 |
| Mar 31, 2022 | 254,674.00 |
| Dec 31, 2021 | 264,840.00 |
| Sep 30, 2021 | 213,880.00 |
| Jun 30, 2021 | 160,731.00 |